Literature DB >> 16495284

Catheter lock and systemic infusion of linezolid for treatment of persistent Broviac catheter-related staphylococcal bacteremia.

Elio Castagnola, Cristina Moroni, Paolo Gandullia, Mauro Oddone, Cristiano Peri, Rosaria Casciaro, Alessandra De Alessandri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16495284      PMCID： PMC1426458          DOI： 10.1128/AAC.50.3.1120-1121.2006

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  5 in total

Review 1.  Guidelines for the management of intravascular catheter-related infections.

Authors:  L A Mermel; B M Farr; R J Sherertz; I I Raad; N O'Grady; J S Harris; D E Craven
Journal:  Clin Infect Dis       Date:  2001-04-03       Impact factor: 9.079

2.  Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus.

Authors:  Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; Fiorenza Orlando; Federico Mocchegiani; Carmela Silvestri; Alberto Licci; Matteo De Fusco; Mauro Provinciali; Vittorio Saba; Giorgio Scalise
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

3.  Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial.

Authors:  Bart J Rijnders; Eric Van Wijngaerden; Stefaan J Vandecasteele; Marguerite Stas; Willy E Peetermans
Journal:  J Antimicrob Chemother       Date:  2004-12-01       Impact factor: 5.790

4.  Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections.

Authors:  John Curtin; Martin Cormican; Gerard Fleming; John Keelehan; Emer Colleran
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

Review 5.  Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial.

Authors:  Dennis J Stalker; Gail L Jungbluth
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447
  5 in total
  1 in total

Review 1.  Antibiotic lock therapy: review of technique and logistical challenges.

Authors:  Julie Ann Justo; P Brandon Bookstaver
Journal:  Infect Drug Resist       Date:  2014-12-12       Impact factor: 4.003
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.